Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 175 of 381 entries
View as:

Text Message Intervention for Alcohol Use and Sexual Violence in College Students

Phase: N/A Priority: Normal
NCT ID: NCT05065918 Org: User:
Start: 11/04/21 End: 08/31/23 Due: 08/31/24

Glutamine Challenge as Predictor of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt (TIPS)

Phase: N/A Priority: Normal
NCT ID: NCT02026609 Org: User:
Start: 05/31/13 End: 01/27/15 Due: 01/27/16

Nutrient Synergy in Beef and Stimulation of Protein Synthesis in Elderly

Phase: N/A Priority: Normal
NCT ID: NCT01415973 Org: User:
Start: 07/31/11 End: 01/31/12 Due: 01/31/13

Impact of a POPOP on Preoperative Health, Eligibility, and Clinical & Patient-Reported Outcomes in TJA

Phase: N/A Priority: Normal
NCT ID: NCT04910048 Org: User:
Start: 01/17/22 End: 09/03/24 Due: 09/03/25

UARK 2012-02 Trial For High-Risk Myeloma Evaluating Accelerating and Sustaining Complete Remission

Phase: N/A Priority: Normal
NCT ID: NCT02128230 Org: User:
Start: 06/10/14 End: 02/19/19 Due: 02/19/20

Treatment of Language and Memory in Patients With Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00593372 Org: User:
Start: 08/31/03 End: 04/30/10 Due: 04/30/11

Movement Assessment for Concussion Management

Phase: N/A Priority: Normal
NCT ID: NCT02776904 Org: User:
Start: 06/01/16 End: 05/01/19 Due: 05/01/20

UARK 2009-32 Compassionate Use Study of Carfilzomib

Phase: N/A Priority: Normal
NCT ID: NCT00999414 Org: User:
Start: 11/30/09 End: 04/30/15 Due: 04/30/16

UARK 2003-41: A Study of High-Dose Density Therapy in Patients With Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00113932 Org: User:
Start: 12/31/03 End: 07/31/10 Due: 07/31/11

Effect of an EAA/Whey Composition on Protein Metabolism

Phase: N/A Priority: Normal
NCT ID: NCT03502941 Org: User:
Start: 06/20/18 End: 07/17/19 Due: 07/17/20

Utilizing Technology to Promote Cancer Prevention

Phase: N/A Priority: Normal
NCT ID: NCT03810053 Org: User:
Start: 03/01/19 End: 07/14/21 Due: 07/14/22

Study of Tumor Antigen-Pulsed Autologous Dendritic Cell Vaccination Administrated Subcutaneously or Intranodally

Phase: N/A Priority: Normal
NCT ID: NCT00083538 Org: User:
Start: 02/28/01 End: 12/31/07 Due: 12/31/08

UARK 2014-21 A Phase II Trial of Oncolytic Virotherapy by Systemic Administration of Edmonston Strain of Measles Virus

Phase: N/A Priority: Normal
NCT ID: NCT02192775 Org: User:
Start: 03/31/15 End: 08/20/19 Due: 08/20/20

Colonoscopy Using Nitrous Oxide- A Pilot Study in the USA

Phase: N/A Priority: Normal
NCT ID: NCT04305158 Org: User:
Start: 03/28/22 End: 08/10/23 Due: 08/10/24

Effects of Gabapentin Versus Placebo on Buprenorphine Detoxification of Opioid-dependent Individuals

Phase: N/A Priority: Normal
NCT ID: NCT01262092 Org: User:
Start: 10/31/10 End: 01/31/12 Due: 01/31/13

Is a Smartphone Application Effective as an Oral Medication Adherence Aid

Phase: N/A Priority: Normal
NCT ID: NCT01968876 Org: User:
Start: 10/30/13 End: 11/14/17 Due: 11/14/18

Therapeutic Research in Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00572338 Org: User:
Start: 08/31/03 End: 03/31/15 Due: 03/31/16

Comparison of Chloroprocaine vs Lidocaine for Epidural Anesthesia in Cesarean Delivery

Phase: N/A Priority: Normal
NCT ID: NCT03414359 Org: User:
Start: 02/15/18 End: 03/27/19 Due: 03/27/20

Understanding GRID Radiation Therapy Effects on Human Tumor Oxygenation and Interstitial Pressure to Increase Translation of Solid Tumor Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01967927 Org: User:
Start: 12/31/13 End: 08/17/21 Due: 08/17/22

Efficacy of Fluorescein Visualization of the Uterus in Detecting Endometrial Cancer Invasion

Phase: N/A Priority: Normal
NCT ID: NCT01979003 Org: User:
Start: 09/30/14 End: 06/30/21 Due: 06/30/22

Panobinostat/Velcade in Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00891033 Org: User:
Start: 04/30/09 End: 08/31/13 Due: 08/31/14

Bone Effect of Bortezomib in Patients With Relapsed/Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT01062230 Org: User:
Start: 01/31/10 End: 08/31/13 Due: 08/31/14

The Regression of Liver Fibrosis and Risk for Hepatocellular Carcinoma (ROLFH) Study

Phase: N/A Priority: Normal
NCT ID: NCT01831037 Org: User:
Start: 07/31/15 End: 12/31/19 Due: 12/31/20

Novel Virtual Reality for Burn Wound Care Pain in Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT03155607 Org: User:
Start: 01/04/18 End: 12/02/21 Due: 12/02/22

Use of a Phosphodiesterase Type 5 Inhibitor to Improve Anabolic Resistance in Older Adults

Phase: N/A Priority: Normal
NCT ID: NCT05458232 Org: User:
Start: 01/20/23 End: 01/20/23 Due: 01/20/24